ARYMX | MGLIX | ARYMX / MGLIX | |
Total Expense Ratio | 1.37 | 0.94 | 146% |
Annual Report Gross Expense Ratio | 1.37 | 0.95 | 144% |
Fund Existence | 14 years | 16 years | - |
Gain YTD | 3.721 | 3.616 | 103% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 2500 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 858M | 2.22B | 39% |
Annual Yield % from dividends | 1.83 | 2.51 | 73% |
Returns for 1 year | 7.62 | 2.42 | 315% |
Returns for 3 years | 13.11 | -3.43 | -383% |
Returns for 5 years | 26.73 | 15.01 | 178% |
Returns for 10 years | 47.03 | 32.21 | 146% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
VYMVX | 18.42 | 0.15 | +0.82% |
Voya Mid Cap Research Enhanced Index R | |||
OPTFX | 90.47 | 0.55 | +0.61% |
Invesco Discovery Large Cap A | |||
MUIGX | 17.56 | 0.07 | +0.40% |
Nationwide BNY Mellon Dyn US Core R6 | |||
GCVRX | 24.29 | 0.07 | +0.29% |
Goldman Sachs Large Cp Val Insghts R | |||
LHCTX | 18.56 | 0.05 | +0.27% |
Lord Abbett Health Care R5 |